84T-21168-47763
3 vaccinations
2 coded responses
32 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 300 / GA
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
UPH-31841-00154
Child or adolescent in my care · Male · 2021-12-21
Timeline
-
2021-02-18
Dose 1 — Pfizer-BioNTech
-
2021-03-02
Registered in v-safe
- 2021-03-02
- 2021-03-04
-
2021-03-11
Dose 2 — Pfizer-BioNTech
- 2021-03-11
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-13
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-17
- 2021-04-22
- 2021-06-12
- 2021-09-09
-
2021-11-09
Dose 3 — Moderna
- 2021-11-09
-
2021-11-11
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-23
-
2021-11-30
Survey response — day 21, dose 3MedDRA: Fatigue, Oropharyngeal pain, Sinus congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Blocked sinuses, sore throat, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-12-07
- 2021-12-14
- 2021-12-21
-
2022-02-08
Survey response — 3 months, dose 3MedDRA: Conjunctivitis, Ear infection, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Ongoing congestion, pink eye and ear infection.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-10
- 2022-05-10
- 2022-11-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Pfizer-BioNTech | |
| 2 | 2021-03-11 | Pfizer-BioNTech | |
| 3 | 2021-11-09 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 21, dose 3
Symptoms: Blocked sinuses, sore throat, fatigue
Release 11 — 3 months, dose 3
Symptoms: Ongoing congestion, pink eye and ear infection.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release